Advertisement
Advertisement
U.S. markets open in 6 hours 36 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Protagonist Therapeutics, Inc. (PTGX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
29.33-2.48 (-7.80%)
At close: 04:00PM EST
29.33 0.00 (0.00%)
After hours: 04:31PM EST
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
Total Revenue
24,390
28,628
231
30,925
Operating Expense
132,049
93,144
80,752
73,194
Operating Income
-107,659
-64,516
-80,521
-42,269
Net Non Operating Interest Income Expense
274
302
2,644
2,546
Other Income Expense
-145
-631
-1
-
Pretax Income
-107,530
-64,845
-77,878
-39,723
Tax Provision
0
1,305
-691
-799
Net Income Common Stockholders
-107,530
-66,150
-77,187
-38,924
Diluted NI Available to Com Stockholders
-107,530
-66,150
-77,187
-38,924
Basic EPS
-
-1.92
-2.98
-1.74
Diluted EPS
-
-1.92
-2.98
-1.74
Basic Average Shares
-
34,396
25,894
22,365
Diluted Average Shares
-
34,396
25,894
22,365
Total Operating Income as Reported
-107,659
-64,516
-80,521
-42,269
Total Expenses
132,049
93,144
80,752
73,194
Net Income from Continuing & Discontinued Operation
-107,530
-66,150
-77,187
-38,924
Normalized Income
-107,530
-65,723
-77,187
-38,924
Interest Income
401
900
2,813
2,546
Interest Expense
127
598
169
-
Net Interest Income
274
302
2,644
2,546
EBIT
-107,403
-64,247
-77,709
-42,269
EBITDA
-104,815
-
-
-
Reconciled Depreciation
2,588
2,564
2,495
527
Net Income from Continuing Operation Net Minority Interest
-107,530
-66,150
-77,187
-38,924
Total Unusual Items Excluding Goodwill
0
-585
-
-
Total Unusual Items
0
-585
-
-
Normalized EBITDA
-104,815
-61,098
-75,214
-41,742
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
-157.95
0
0
Advertisement
Advertisement